ISLAMABAD, Dec 1: Several essential medicines are out of market ostensibly because of an artificial shortage created by their multinational manufacturers in a bid to extract maximum concessions from the government ahead of finalisation of its drug pricing policy.

The crisis is being described by some people in medical circles as the worst in recent years because even some of the most common medicines like Panadol have disappeared from chemists’ shelves across the country, and stocks of several prescription drugs manufactured by multinationals in different parts of the country have rapidly depleted. Included among these are Augmentin and Wymox capsules, Mucaine syrup, Ventolin inhaler, Actifed, Betnovate-N cream, Polyfax ointments (skin & eye), Pyodine, Polycrol syrup, Gaviscone syrup, Angisid tablets, Thyroxine, Atem inhaler, Neomercazole, Cicatrin power, Distalgesic tablets, Septran syrup, Amoxil capsules and Buscopan, Maxolon, and Gravinate tablets. The list is by no means exhaustive.

Most of these drugs are on WHO’s list of essential medicines.

Salespersons in Islamabad’s leading chemist stores confirmed that most of the drugs had been short in supply for sometime. Mr M. Fazal of the Shaheen Chemists said the drugs had been either in short supply or not available at all.

Mohammad Hussain, who works at the D. Watson Chemists, said the shortage had been there for quite a few weeks.

Sources in the pharmaceutical industry indicated that it was an artificial shortage created by manufacturers in anticipation of a new official pricing formula for medicines. The new formula is expected to be announced by the end of this month and is likely to significantly raise prices.

According to sources, some multinational companies have slowed down production and it was a pre-planned shortage.

The companies, a senior health ministry official said, were eyeing a massive 35 per cent hike in prices.

Former Pharma Bureau chief Jeurgen Konig had indicated in an interview with Dawn in June that the multinational companies might cut the supply of their products if they did not get a price hike from the health ministry.

There has been no official increase in the prices of drugs since December, 2001.

However, despite regulatory restrictions local pharmaceutical companies have on a number of occasions enhanced prices of their products. The last raise of some 5 per cent was made late last month.

The tactics of multinational companies have already started yielding desired results.

Health Ministry’s Director General Dr Rashid Juma told Dawn that the new formula would provide ‘relief’ on the old registered drugs of multinational companies.

Qaiser Waheed, one of the leaders of the Pakistan Pharmaceutical Manufacturers Association, an umbrella organisation of local manufacturers, says that the situation has aggravated because of excessive reliance by doctors on drugs produced by multinationals.

Opinion

Editorial

PTI in disarray
Updated 30 Nov, 2024

PTI in disarray

PTI’s protest plans came abruptly undone because key decisions were swayed by personal ambitions rather than political wisdom and restraint.
Tired tactics
30 Nov, 2024

Tired tactics

Matiullah's arrest appears to be a case of the state’s overzealous and misplaced application of the law.
Smog struggle
30 Nov, 2024

Smog struggle

AS smog continues to shroud parts of Pakistan, an Ipsos survey highlights the scope of this environmental hazard....
Solidarity with Palestine
Updated 29 Nov, 2024

Solidarity with Palestine

The wretched of the earth see in the Palestinian struggle against Israel a mirror of themselves.
Little relief for public
29 Nov, 2024

Little relief for public

INFLATION, the rate of increase in the prices of goods and services over a given period of time, has receded...
Right to education
29 Nov, 2024

Right to education

IT is troubling to learn that over 16,500 students of the University of Karachi (KU) have defaulted on fee payments...